Matches in SemOpenAlex for { <https://semopenalex.org/work/W2042874611> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2042874611 endingPage "162" @default.
- W2042874611 startingPage "155" @default.
- W2042874611 abstract "Midazolam is being selected increasingly for use in patients with cardiovascular compromise. Although clinical doses of midazolam have minimal effects on cardiac function, the influence of midazolam (and other benzodiazepine sedatives) on cardiac arrhythmogenesis has yet to be elucidated fully.In this study, we investigated the effect of midazolam, with and without flumazenil, on the arrhythmogenic serum concentration of epinephrine (ACE) in six halothane-anesthetized dogs. Midazolam was administered as a loading dose (1.5 mg/kg over 5 min) followed by a 4.5-h infusion at two rates (10 and 40 micrograms.kg-1 x min-1) to achieve and maintain predetermined clinical and supraclinical plasma midazolam concentrations. The arrhythmogenic serum concentration of epinephrine determinations were made prior to midazolam infusion, following 2 h of midazolam infusion and following 3.5 h of midazolam infusion and 1 mg flumazenil/kg i.v. Saline control studies were also performed in four of the six dogs.Plasma midazolam concentrations ranged from 363 to 855 ng/ml in the low-dose infusion study, essentially spanning the clinically effective range for humans. In the high-dose infusion study, plasma midazolam concentrations were up to four times greater, ranging from 1168 to 3563 ng/ml. The arrhythmogenic serum concentration of epinephrine values were unchanged following low-dose midazolam infusion and saline. In the high-dose study, ACE increased from baseline values of 68 +/- 13 (SEM) ng/ml to 112 +/- 25 ng/ml (P = .03) following midazolam infusion and decreased to 79 +/- 13 ng/ml with flumazenil administration. Plasma midazolam concentrations, however, were poorly correlated with ACE values normalized for control ACE (ACE ratio). Diastolic arterial pressure was significantly depressed following both low-dose (-14%) and high-dose (-19%) midazolam infusion. This decrease in blood pressure was unaffected by flumazenil administration. Other hemodynamic parameters were unaffected by drug treatment.This study has demonstrated that midazolam infusion results in either no effect (with clinical plasma midazolam concentrations) or flumazenil-reversible suppression (with supraclinical concentrations) of halothane-epinephrine arrhythmogenesis." @default.
- W2042874611 created "2016-06-24" @default.
- W2042874611 creator A5007922621 @default.
- W2042874611 creator A5033215111 @default.
- W2042874611 creator A5056184039 @default.
- W2042874611 creator A5075162659 @default.
- W2042874611 creator A5087737186 @default.
- W2042874611 date "1993-01-01" @default.
- W2042874611 modified "2023-09-23" @default.
- W2042874611 title "Effect of Midazolam Infusion and Flumazenil Administration on Epinephrine Arrhythmogenicity in Dogs Anesthetized with Halothane" @default.
- W2042874611 doi "https://doi.org/10.1097/00000542-199301000-00021" @default.
- W2042874611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8424549" @default.
- W2042874611 hasPublicationYear "1993" @default.
- W2042874611 type Work @default.
- W2042874611 sameAs 2042874611 @default.
- W2042874611 citedByCount "7" @default.
- W2042874611 crossrefType "journal-article" @default.
- W2042874611 hasAuthorship W2042874611A5007922621 @default.
- W2042874611 hasAuthorship W2042874611A5033215111 @default.
- W2042874611 hasAuthorship W2042874611A5056184039 @default.
- W2042874611 hasAuthorship W2042874611A5075162659 @default.
- W2042874611 hasAuthorship W2042874611A5087737186 @default.
- W2042874611 hasBestOaLocation W20428746111 @default.
- W2042874611 hasConcept C126322002 @default.
- W2042874611 hasConcept C170493617 @default.
- W2042874611 hasConcept C2775859304 @default.
- W2042874611 hasConcept C2776814716 @default.
- W2042874611 hasConcept C2777397205 @default.
- W2042874611 hasConcept C2778000748 @default.
- W2042874611 hasConcept C2778173252 @default.
- W2042874611 hasConcept C2778409475 @default.
- W2042874611 hasConcept C42219234 @default.
- W2042874611 hasConcept C71924100 @default.
- W2042874611 hasConceptScore W2042874611C126322002 @default.
- W2042874611 hasConceptScore W2042874611C170493617 @default.
- W2042874611 hasConceptScore W2042874611C2775859304 @default.
- W2042874611 hasConceptScore W2042874611C2776814716 @default.
- W2042874611 hasConceptScore W2042874611C2777397205 @default.
- W2042874611 hasConceptScore W2042874611C2778000748 @default.
- W2042874611 hasConceptScore W2042874611C2778173252 @default.
- W2042874611 hasConceptScore W2042874611C2778409475 @default.
- W2042874611 hasConceptScore W2042874611C42219234 @default.
- W2042874611 hasConceptScore W2042874611C71924100 @default.
- W2042874611 hasIssue "1" @default.
- W2042874611 hasLocation W20428746111 @default.
- W2042874611 hasLocation W20428746112 @default.
- W2042874611 hasOpenAccess W2042874611 @default.
- W2042874611 hasPrimaryLocation W20428746111 @default.
- W2042874611 hasRelatedWork W1984850066 @default.
- W2042874611 hasRelatedWork W2023963305 @default.
- W2042874611 hasRelatedWork W2032464090 @default.
- W2042874611 hasRelatedWork W2065899116 @default.
- W2042874611 hasRelatedWork W2067986278 @default.
- W2042874611 hasRelatedWork W2124345810 @default.
- W2042874611 hasRelatedWork W2410177344 @default.
- W2042874611 hasRelatedWork W2468027486 @default.
- W2042874611 hasRelatedWork W4298149653 @default.
- W2042874611 hasRelatedWork W4299966385 @default.
- W2042874611 hasVolume "78" @default.
- W2042874611 isParatext "false" @default.
- W2042874611 isRetracted "false" @default.
- W2042874611 magId "2042874611" @default.
- W2042874611 workType "article" @default.